PharmaFluidics’ µPAC™ capLC is evaluated for different user needs ranging from 12 samples per day in comprehensive mode to 65 samples per day in throughput mode.
PharmaFluidics introduces a new µPAC™ capLC column that offers unprecedented performance and that given its low backpressure can be used with flow rates of up to 15μL/min.
µPAC™ technology has been used for analysing HCP impurities originating from recombinant expression systems used in the production of mAb based biotherapeutics.
PharmaFluidics also offers a 50 cm long µPAC™ column which is perfectly suited to perform more throughput analyses with shorter gradient solvent times.
Overall gain in performance and increase in detection sensitivity that can be achieved for the separation of plant metabolite extracts by using µPAC™ columns.
PharmaFluidics’ µPAC™ columns have the potential to be less prone to sample related column failure and to withstand more sample injections without losing performance.
Monitoring the excellent separation performance of PharmaFluidics’ µPAC™ columns by using peptide retention time calibration mixtures for bottom-up proteomics.
